Patrick D Walsh, a director at $ANIP, sold 9,000 shares of the company on 08-15-2025 for an estimated $801,450. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.4% of their shares of this class of stock. Following this trade, they now own 70,048 shares of this class of $ANIP stock.
$ANIP Insider Trading Activity
$ANIP insiders have traded $ANIP stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $ANIP stock by insiders over the last 6 months:
- MUTHUSAMY SHANMUGAM (HEAD OF R&D, COO-NOVITIUM OPS) has made 0 purchases and 3 sales selling 100,700 shares for an estimated $8,878,314.
- NIKHIL LALWANI (PRESIDENT & CEO) sold 56,960 shares for an estimated $4,894,572
- STEPHEN P. CAREY (SVP & CFO) sold 50,000 shares for an estimated $4,303,500
- CHAD GASSERT (SVP - CORP. DEV. & STRATEGY) sold 20,000 shares for an estimated $1,739,400
- THOMAS HAUGHEY sold 19,341 shares for an estimated $1,661,972
- ORI GUTWERG (SVP, GENERICS) has made 0 purchases and 4 sales selling 12,138 shares for an estimated $884,161.
- PATRICK D WALSH sold 9,000 shares for an estimated $801,450
- THOMAS ANDREW ROWLAND (SVP, HEAD - ESTABLISHED BRANDS) sold 4,975 shares for an estimated $426,407
- KRISTA DAVIS (SVP, CHIEF HR OFFICER) has made 0 purchases and 3 sales selling 3,866 shares for an estimated $242,350.
- CHRISTOPHER MUTZ (HEAD OF RARE DISEASE) sold 4,000 shares for an estimated $241,800
- MEREDITH COOK (SR. VP, GENERAL COUNSEL & SEC.) has made 0 purchases and 6 sales selling 2,400 shares for an estimated $163,844.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ANIP Hedge Fund Activity
We have seen 113 institutional investors add shares of $ANIP stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC removed 426,166 shares (-67.5%) from their portfolio in Q2 2025, for an estimated $27,807,331
- NUVEEN, LLC added 322,375 shares (+663.3%) to their portfolio in Q2 2025, for an estimated $21,034,968
- MORGAN STANLEY removed 236,577 shares (-54.1%) from their portfolio in Q2 2025, for an estimated $15,436,649
- RUBRIC CAPITAL MANAGEMENT LP added 200,998 shares (+354.7%) to their portfolio in Q2 2025, for an estimated $13,115,119
- FREESTONE GROVE PARTNERS LP added 191,217 shares (+4784.0%) to their portfolio in Q2 2025, for an estimated $12,476,909
- MILLENNIUM MANAGEMENT LLC added 185,535 shares (+22.7%) to their portfolio in Q2 2025, for an estimated $12,106,158
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 173,941 shares (-77.4%) from their portfolio in Q2 2025, for an estimated $11,349,650
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ANIP Analyst Ratings
Wall Street analysts have issued reports on $ANIP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 08/08/2025
- Guggenheim issued a "Buy" rating on 05/12/2025
- Jefferies issued a "Buy" rating on 03/14/2025
- JP Morgan issued a "Overweight" rating on 03/12/2025
To track analyst ratings and price targets for $ANIP, check out Quiver Quantitative's $ANIP forecast page.
$ANIP Price Targets
Multiple analysts have issued price targets for $ANIP recently. We have seen 6 analysts offer price targets for $ANIP in the last 6 months, with a median target of $85.5.
Here are some recent targets:
- Gregory Fraser from Truist Securities set a target price of $77.0 on 08/11/2025
- Brandon Folkes from HC Wainwright & Co. set a target price of $93.0 on 08/08/2025
- Vamil Divan from Guggenheim set a target price of $86.0 on 05/12/2025
- Glen Santangelo from Jefferies set a target price of $80.0 on 03/14/2025
- Ekaterina Knyazkova from JP Morgan set a target price of $85.0 on 03/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
